System and kit for detecting fowl adenovirus FAdV-4 based on CRISPR-Cas12a and application

Through the CRISPR-Cas12a detection system, the nucleic acid cleavage and fluorescence signal release of FAdV-4 virus by combining Cas12a protein with crRNA is solved, and the problem of long detection time and insufficient sensitivity in the prior art is solved, achieving rapid, sensitive and simple specificity Test.

CN118910329AActive Publication Date: 2024-11-08SOUTH CHINA AGRICULTURAL UNIVERSITY +1
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411075408.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-07
Publication Date
2024-11-08
Estimated Expiration
2044-08-07

AI Technical Summary

Technical Problem

The existing FAdV-4 technology for detecting avian adenovirus is difficult to achieve fast, sensitive, simple and specific on-site detection, and the detection time is long and the sensitivity is not enough to meet the actual needs.

Method used

Using a detection system based on CRISPR-Cas12a, the Cas12a protein binds to crRNA to form an RNP complex, forward cleavage of FAdV-4 viral nucleic acid, and reverse cleavage of ssDNA-reporter labeled with fluorescent groups to achieve rapid Test.

Benefits of technology

Fast, sensitive, simple and highly specific FAdV-4 virus detection is achieved, which reduces detection time, improves sensitivity, can be applied in the field, and can specifically identify FAdV-4 viruses.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118910329A_ABST
    Figure CN118910329A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of biology, and discloses a system for detecting fowl adenovirus FAdV-4 based on CRISPR-Cas12a, the system comprises a first RPA primer pair and a second RPA primer pair which are respectively designed aiming at a Fiber2 gene and a Hexon gene of the fowl adenovirus FAdV-4, a Cas12a protein, crRNA-Fiber2, crRNA-Hexon and ssDNA-report, and the first RPA primer pair and the second RPA primer pair are respectively designed aiming at the Fiber2 gene and the Hexon gene of the fowl adenovirus FAdV-4. In addition, the invention also discloses a kit for detecting the fowl adenovirus FAdV-4 based on the CRISPR-Cas12a, and the kit comprises the system and also comprises a Buffer, RNase-free H2O, an Rnase Inhibitor and a DNA (Deoxyribonucleic Acid) plasmid.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of biological detection technology, and in particular to a system, a kit, and an application for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a. Background Art

[0002] Avian adenovirus disease is a common disease in poultry farming that is highly pathogenic and contagious. As a pathogen, avian adenovirus (FAdV) has three major groups - serogroup I, group II and group III, which can cause hydropericardium syndrome and inclusion body hepatitis in chickens, hemorrhagic enteritis in turkeys and splenomegaly in chickens, and egg production decline syndrome in chickens. FAd V-Ⅰ can be divided into 5 species and 12 serotypes, including A (serotype 1), B (serotype 5), C (serotypes 4 and 10), D (serotypes 2, 3, 9, and 11), and E (serotypes 6, 7, 8a, and 8b). Over the years, the number of clinical cases of poultry infected with group I adenovirus has increased dramatically. Among them, hydropericardium syndrome (HPS) caused by serotype 4 (FAdV-4) has a rapid onset, fast spread, and high mortality, causing serious economic losses to the domestic poultry industry.

[0003] The disease is more common in broilers and growing chickens between 20 and 60 days old, and laying hens at 300 days old are also susceptible to the disease. FAdV-4 is a virus with a distinct characteristic pathogenic age range. It is most pathogenic to chicks, with a mortality rate of up to 100%, but with age, its mortality rate gradually decreases. The virus can be transmitted not only vertically but also horizontally. The main characteristic pathological changes of this disease are the accumulation of clear or light yellow watery or jelly-like fluid in the pericardial cavity of dead chickens, and myocardial weakness.

[0004] Chinese patent application 202210842143.1 discloses a CRISPR-Cas13 system, a kit and a method for detecting FAdV-4, wherein the CRISPR-Cas13 system includes a Cas13a nuclease, a guide RNA probe and an FB-RNA reporter molecule; the guide RNA probe targets the Hexon gene of avian adenovirus serotype 4, and the Cas13a nuclease activates the enzyme activity after the guide RNA probe recognizes the target gene, and cuts the FB-RNA reporter molecule to release a detection signal.

[0005] This detection system uses a two-step method for detection, and the entire process takes about 70 minutes. The lower limit of the plasmid copy number that can be detected in the primer and probe combination provided is 10 copies / μL.

[0006] The problem that this scheme needs to solve is: how to prepare a rapid, sensitive, simple and specific FAdV-4 test kit that can be used on-site. Summary of the invention

[0007] The purpose of this application is to provide a system and kit for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a, by which the Cas12a protein binds to crRNA, thereby guiding the Cas12a protein to perform positive cleavage of viral nucleic acid, while also having the ability to non-specifically cleave ssDNA.

[0008] To achieve the above object, a system for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a is provided herein, characterized in that the system for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a comprises a first RPA primer pair, a second RPA primer pair, Cas12a protein, crRNA-Fiber2, crRNA-Hexon, ssDNA-reporter, and DNA plasmid;

[0009] The first RPA primer pair includes an upstream primer RPA-FI-F and a downstream primer RPA-FI-R, and the first RPA primer pair is designed for the Fiber2 gene of avian adenovirus FAdV-4;

[0010] The second RPA primer pair includes an upstream primer RPA-HE-F and a downstream primer RPA-HE-R, and the second RPA primer pair is designed for the Hexon gene of avian adenovirus FAdV-4;

[0011] The crRNA-Fiber2 is designed for the Fiber2 gene of fowl adenovirus FAdV-4;

[0012] The crRNA-Hexon is designed for the Hexon gene of avian adenovirus FAdV-4;

[0013] In the working process of the CRISPR-Cas12a-based system for detecting avian adenovirus FAdV-4, when crRNA-Fiber2 or crRNA-Hexon forms a ternary complex with DNA plasmid and Cas12a protein, the Cas12a protein is guided to forward-cleave the amplification products of the first RPA primer pair and the second RPA primer pair, and at the same time, the Cas12a protein spontaneously reverse-cuts the ssDNA-reporter and releases the fluorescent group.

[0014] Preferably, the sequence of the upstream primer RPA-FI-F in the first RPA primer pair is shown as SEQ ID NO.1;

[0015] The sequence of the downstream primer RPA-FI-R of the first RPA primer pair is shown in SEQ ID NO.2;

[0016] The sequence of the upstream primer RPA-HE-F of the second RPA primer pair is shown in SEQ ID NO.3;

[0017] The sequence of the downstream primer RPA-HE-R of the second RPA primer pair is shown as SEQ ID NO.4.

[0018] Preferably, the sequence of the crRNA-Fiber2 upstream primer crRNA-Fiber2-F is as shown in SEQ ID NO.5;

[0019] The sequence of the crRNA-Fiber2 downstream primer crRNA-Fiber2-R is as shown in SEQ ID NO.6;

[0020] The sequence of the crRNA-Hexon upstream primer crRNA-Hexon-F is as shown in SEQ ID NO.7;

[0021] The sequence of the crRNA-Hexon downstream primer crRNA-Hexon-R is shown in SEQ ID NO.8.

[0022] Preferably, the ssDNA-reporter is a single-stranded nucleotide sequence labeled with FAM at the 5' end and BHQ1 at the 3' end, or a single-stranded nucleotide sequence labeled with FAM at the 5' end and Biotin at the 3' end.

[0023] Preferably, the ssDNA-reporter is ssDNA-reporter-CLA or ssDNA-reporter-LFA, and the nucleotide sequence of the ssDNA-reporter-CLA is 5'-FAM-TTATT-BHQ1-3';

[0024] The nucleotide sequence of the ssDNA-reporter-LFA is 5'-FAM-TTTTTTTTTTTTTTT-Bi otin-3'.

[0025] In addition, a kit for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a is also disclosed, comprising any of the above-mentioned systems for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a.

[0026] Preferably, the kit further comprises Buffer, RNase-free H2O, and RNase Inhibitor.

[0027] The beneficial effects of this application are:

[0028] The present application provides a system and a kit for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a. The kit can be used for on-site detection and has the characteristics of being rapid, sensitive, simple and specific to the FAdV-4 virus. The Cas12a protein in the system combines with crRNA and DNA plasmid to form an RNP complex, and the crRNA guides the complex to perform forward cutting of the FAdV-4 viral nucleic acid, and at the same time, reverse cutting of the ssDNA-reporter labeled with a fluorescent group is also performed to achieve detection. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 Screening fluorescence results for 8 pairs of crRNA;

[0030] Figure 2 This is the electrophoresis result of 7 pairs of RPA primers screening in one tube method;

[0031] Figure 3 The electrophoresis results of screening three pairs of RPA primers for the two-step method;

[0032] Figure 4 The fluorescence results of ssDNA at different concentrations;

[0033] Figure 5 is the fluorescence value of ssDNA at different concentrations;

[0034] Figure 6 is the fluorescence value of different ratios of Lbcas12a and crRNA;

[0035] Figure 7 To specifically detect fluorescence results;

[0036] Figure 8 To specifically detect the fluorescence value;

[0037] Fig. 9 This is the sensitivity test result of the one-step method. Three replicate wells were made for each dilution factor. From tube 1 to tube 11, the results are: 7.17*10 9 copy / ul, 7.17*10 8 copy / ul, 7.17*10 7 copy / ul, 7.17*10 6 copy / ul, 7.17*10 5 copy / ul, 7.17*10 4 copy / ul, 7.17*10 3 copy / ul, 7.17*10 2 copy / ul, 7.17*10 1 copy / ul, 7.17*100 copy / ul, 7.17*10 -1 copy / ul, negative control;

[0038] Fig.10 To detect the baseline fluorescence results in one step, three replicate wells were made for each dilution factor, which were 7.84*10 2 *1 / 2copy / ul, 196copy / ul, 98copy / ul, 49copy / ul, negative control;

[0039] Fig.11 The fluorescence detection results of the two-step method are 1.40*10 from left to right. 10 copy / ul, 1.40*10 9 copy / ul, 1.40*10 8 copy / ul, 1.40*10 7 copy / ul, 1.40*10 6 copy / ul, 1.40*10 5 copy / ul, 1.40*10 4 copy / ul, 1.40*10 3 copy / ul, 1.40*10 2 copy / ul, 1.40*10 1 copy / ul, 7copy / ul, 3.5copy / ul, 1.75copy / ul, 0.875copy / ul;

[0040] Fig.12 It is the test result of two-step sensitivity test strip;

[0041] Fig.13 It is the test result of two-step sensitivity test strip;

[0042] Fig.14 The fluorescence results of 19 clinically positive samples were detected by one tube method;

[0043] Fig.15 The fluorescence results of 19 clinically positive samples were detected by the two-step method;

[0044] Fig.16 The fluorescence results of 50 random samples were tested by one tube method;

[0045] Fig.17 Results of 50 random samples tested by qPCR. DETAILED DESCRIPTION

[0046] In the description of this application, it should be noted that if the specific conditions are not specified in the examples, the experiments were carried out according to conventional conditions or the conditions recommended by the manufacturer. The reagents or instruments used, if the manufacturer is not specified, are all conventional products that can be purchased commercially.

[0047] Example 1

[0048] Design and screening of RPA primer sets

[0049] Targeting FAdV4 fiber2 gene (GenBank accession no. MW509553.1), we used snapgene to perform sequence alignment, analyzed the conserved regions, and designed 7 pairs of RPA primers, which were synthesized by Sangon Biotechnology (PAGE purification). After testing and screening, the final set was selected as follows:

[0050] RPA-FI-F: 5'-AAGTCCCAGCCTCAACACCTACAATGCCACGA-3';

[0051] RPA-FI-R: 5'-CCATTTGGCATTGGCGGAGTTGAGGTCCCCAG-3';

[0052] The size of the amplified fragment was 152 bp;

[0053] Three pairs of RPA primers were designed for FAdV4 Hexon gene (GenBank accession no.MN102413.1), synthesized by Qingke Biotechnology (PAGE purification), and the following set was finally selected after testing and screening:

[0054] RPA-HE-F: 5'-ATTAAACTCTACACCAACAACACCGCCGCGAAC-3';

[0055] RPA-HE-R: 5'-CGTCGAAGCCGGAGATGCTAAACTTGTAACGGTC-3';

[0056] The size of the amplified fragment was 162 bp;

[0057] Example 2

[0058] Design and screening of crRNA

[0059] The PAM sequence recognized by Cas12a is TTTN. In the two-step method, the TTTN-type PAM sequence is selected. In the one-tube method, the TTTN-type PAM sequence is not used. The suboptimal PAM sequence is selected, that is, the suboptimal sequence. Eight pairs of crRNAs are designed and synthesized and purified by GeneWeichi. The crRNA sequences are shown in Table 1:

[0060] Table 1

[0061]

[0062]

[0063] according to Figure 1 As shown in the fluorescence results, the crRNA-Fiber2 primer set was designed based on the crRNA1 primer set, including the following primers:

[0064] crRNA-Fiber2-F: 5'-GAAATTAATACGACTCACTATAGGGtaatttctactaagtgtagatCTTGAAATTGGACAGCGCCACCA-3';

[0065] crRNA-Fiber2-R: 5'-TGGTGGCGCTGTCCAATTTCAAGatctacacttagtagaaattaCCCTATAGTGAGTCGTATTAATTTC-3';

[0066] The crRNA-Hexon primer set was designed by software and includes the following primers:

[0067] crRNA-Hexon-F: 5'-GAAATTAATACGACTCACTATAGGGTAATTTCTACTAAGTGTAGATGTAGGAGGGTACCGTGCCGAAGT-3';

[0068] crRNA-Hexon-R: 5'-ACTTCGGCACGGTACCCTCCTACATCTACACTTAGTAGAAATTACCCTATAGTGAGTCGTATTAATTTC-3';

[0069] Annealing system: upstream primer 10ul, downstream primer 10ul, buffer 10ul, ddH2O 20ul; PCR program settings: 95℃2min, 95℃options increment-0.1℃8s, 700X, stored at 4℃.

[0070] The DNA double strand was transcribed into RNA using the T7 in vitro transcription kit (HiScribe T7 Quick High Yield RNA Synthesis Kit), purified using the NucleoSpin RNA Clean-up (Macherey-Nagel) kit, and the concentration was measured on the NanoDrop. The purified crRNA was frozen in a -80°C refrigerator. The T7 transcription is as follows:

[0071] The annealed crRNA1-5 was transcribed in vitro using Novoprotein's T7 high yield transcript kit according to the instructions. The DNA template concentration was 1 μg / μl, and the transcription was performed at 37°C for 16 h. The components and contents of the transcription kit are shown in Table 2:

[0072] Table 2

[0073] Element Volume (20 μl) Reaction Buffer 2μl ATP / GTP / CTP / UTP Solution 1.5 μl each DNA TemplateX 0.5~1.0μg T7 RNA Polymerase Mix 2μl <![CDATA[RNase free H2O]]> Up to 20μl

[0074] Example 3

[0075] Establishment of RPA-CRISPR-Cas12a method

[0076] 1. The content of each component detected by RPA-CRISPR-Cas12a one-tube method is:

[0077] RPA component 18ul (including 10uM RPA-FI-F 2ul, 10uM RPA-FI-R 2ul, ABuffer 29.4ul, RNase-free H2O 14.1ul), Lbcas12a 100nM, crRNA 75nM, ssDNA-reporter-CLA 400nM, Rnase Inhibitor 0.5ul, B Buffer 2ul, plasmid DNA 2ul, RNase-free H2O add to 28ul, mix well, and react at 37°C in the dark for 40min.

[0078] 2. Detection by the two-step method of RPA-CRISPR-Cas12a:

[0079] RPA amplification reaction system: 10uM RPA-HE-F 2ul, 10uM RPA-HE-R 2ul, A buffer 29.4ul, RNase-free H2O 11.1ul, B buffer 2.5ul, plasmid DNA 1.5ul, react at 37℃ for 25min.

[0080] The CRISPR-Cas12a cleavage reaction system is: RNase inhibitor 0.5ul, ssDNA-reporter-CLA400nM / ssDNA-reporter-LFA 400nM, crRNA 100nM, Lbcas12a 100nM, NE Buffer2.1 2ul, RPA amplification product 3ul, RNase-free H2O added to 20ul, and reacted at 37°C in the dark for 25min.

[0081] Example 4

[0082] Screening of crRNA with the highest efficiency: According to the method of Example 3, 8 pairs of crRNA were screened and the crRNA with better results was selected. The fluorescence results are as follows Figure 1 As shown, crRNA1 showed better results and had higher sensitivity among all crRNAs.

[0083] Example 5

[0084] Screening of RPA primer sets: According to the RPA amplification method in Example 3, 10 pairs of RPA primers were screened, and the RPA amplification products were subjected to 1.5% agarose gel electrophoresis to observe the band positions and brightness depths. The results are as follows: Figure 2-3 As shown, RPA Primer 3 and RPA Primer 1 were selected.

[0085] Example 6

[0086] Exploring ssDNA concentration: According to the method in Example 3, four groups of ssDNA-reporter concentrations were set, namely 100 nM for group D, 200 nM for group C, 300 nM for group B, and 400 nM for group A, and the optimal concentration was screened. The results are as follows: Figure 4-5 As shown, the optimal concentration was 400 nM in group A.

[0087] Example 7

[0088] Exploration of the ratio of Lbcas12a to crRNA: According to the method of Example 3, four groups of Lbcas12a and crRNA concentration ratios were set, respectively:

[0089] Experimental group 1: Lbcas12a: crRNA = 100 nm: 100 nm;

[0090] Experimental group 2: Lbcas12a: crRNA = 100 nm: 200 nm;

[0091] Experimental group 3: Lbcas12a: crRNA = 50 nm: 100 nm;

[0092] Experimental group 4: Lbcas12a: crRNA = 50 nm: 50 nm;

[0093] The results are as follows Figure 6 As shown, the ratio shown in experimental group 1 is the best.

[0094] Example 8

[0095] RPA-CRISPR-Cas12a detects FAdV-4 specificity analysis: According to the method of Example 3, the detection includes chicken infectious bronchitis virus (IBV), chicken infectious bursal disease virus (IBDV), Newcastle disease virus (NDV), chicken Marek's virus (MDV), fowl adenovirus serotype 8b and fowl adenovirus serotype 11. The results are as follows Figure 7-8 As shown, no fluorescence was detected, indicating specificity.

[0096] Example 9

[0097] RPA-CRISPR-Cas12a sensitivity assay:

[0098] 1. One-tube method

[0099] Dilute the plasmid standard: dilute the plasmid standard containing the FAdV-4fiber2 gene fragment with RNase free H2O from 7.84*10 10 copy / ul ten-fold dilution to 7.84*10 2 copy / ul, and then dilute half to 49copy / ul;

[0100] The diluted plasmid was tested according to the one-tube method system of Example 3. The results are as follows Figure 9-10 As shown, the minimum detection limit is 98copy / ul.

[0101] 2. Two-step method

[0102] Dilute the plasmid standard: dilute the plasmid standard containing the FAdV-4 hexon gene fragment with RNase free H2O to 1.40*10 11 copy / ul ten-fold dilution to 1.40*10 1 copy / ul, and then dilute to 0.875copy / ul;

[0103] The diluted plasmid was detected by the two-step system of Example 3, and the results were checked by fluorescence and lateral flow chromatography (colloidal gold method), respectively. Figure 11-13 As shown, the minimum detection limit of lateral flow detection (colloidal gold method) is 14 copy / ul, and the minimum detection limit of fluorescence method is 7 copy / ul.

[0104] Example 10

[0105] RPA-CRISPR-Cas12a detection of clinical samples: According to the method in Example 3, 19 positive samples infected with FAdV-4 were tested using the one-tube method and the two-step method, and a negative control was set for each group. The results are as follows Figure 14-15 As shown, all were positive.

[0106] Embodiment 11

[0107] RPA-CRISPR-Cas12a repeatability test: According to the method of Example 3, 50 samples to be tested were tested using the one-tube method and fluorescent quantitative PCR, including 38 positive samples (positive tissue disease materials and allantoic fluid) and 12 negative samples. The results are as follows: Fig.16 , 17 As shown in Table 3, the results of the one-tube method test were 12 negative and 38 positive; the results of the qPCR test were 12 negative and 38 positive, and the consistency rate of the two was 100%. The test results are shown in Table 3:

[0108] Table 3

[0109]

[0110] The above embodiments are preferred implementation modes of the present application, but the implementation modes of the present application are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications made without departing from the spirit and principles of the present application shall be equivalent replacement methods and shall be included in the protection scope of the present application.

Claims

1. A system for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a, It is characterized in that The system for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a includes a first RPA primer pair, a second RPA primer pair, Cas12a protein, crRNA-Fiber2, crRNA-Hexon, ssDNA-reporter, and a DNA plasmid; The first RPA primer pair includes an upstream primer RPA-FI-F and a downstream primer RPA-FI-R, and the first RPA primer pair is designed for the Fiber2 gene of avian adenovirus FAdV-4; The second RPA primer pair includes an upstream primer RPA-HE-F and a downstream primer RPA-HE-R, and the second RPA primer pair is designed for the Hexon gene of avian adenovirus FAdV-4; The crRNA-Fiber2 is designed for the Fiber2 gene of fowl adenovirus FAdV-4; The crRNA-Hexon is designed for the Hexon gene of avian adenovirus FAdV-4; In the working process of the CRISPR-Cas12a-based system for detecting avian adenovirus FAdV-4, when crRNA-Fiber2 or crRNA-Hexon forms a ternary complex with DNA plasmid and Cas12a protein, the Cas12a protein is guided to forward-cleave the amplification products of the first RPA primer pair and the second RPA primer pair, and at the same time, the Cas12a protein spontaneously reverse-cuts the ssDNA-reporter and releases the fluorescent group.

2. The system for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a according to claim 1, It is characterized in that The sequence of the upstream primer RPA-FI-F in the first RPA primer pair is shown in SEQ ID NO.1; The sequence of the downstream primer RPA-FI-R of the first RPA primer pair is shown in SEQ ID NO.2; The sequence of the upstream primer RPA-HE-F of the second RPA primer pair is shown in SEQ ID NO.3; The sequence of the downstream primer RPA-HE-R of the second RPA primer pair is shown in SEQ ID NO.

4.

3. The system for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a according to claim 1, It is characterized in that The sequence of the crRNA-Fiber2 upstream primer crRNA-Fiber2-F is as shown in SEQ ID NO.5; The sequence of the crRNA-Fiber2 downstream primer crRNA-Fiber2-R is as shown in SEQ ID NO.6; The sequence of the crRNA-Hexon upstream primer crRNA-Hexon-F is as shown in SEQ ID NO.7; The sequence of the crRNA-Hexon downstream primer crRNA-Hexon-R is shown in SEQ ID NO.

8.

4. The system for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a according to claim 1, It is characterized in that The ssDNA-reporter is a single-stranded nucleotide sequence labeled with FAM at the 5' end and BHQ1 at the 3' end, or a single-stranded nucleotide sequence labeled with FAM at the 5' end and Biotin at the 3' end.

5. The system for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a according to claim 4, It is characterized in that The ssDNA-reporter is ssDNA-reporter-CLA or ssDNA-reporter-LFA, and the nucleotide sequence of the ssDNA-reporter-CLA is 5'-FAM-TTATT-BHQ1-3'; The nucleotide sequence of the ssDNA-reporter-LFA is 5'-FAM-TTTTTTTTTTTTTTT-Bi otin-3'.

6. A kit for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a, It is characterized in that The invention comprises a system for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a as described in any one of claims 1 to 5.

7. The kit for detecting avian adenovirus FAdV-4 based on CRISPR-Cas12a according to claim 6, It is characterized in that It also includes Buffer, RNase-free H 2 O. RNase Inhibitor.

Citation Information

Patent Citations

  • CRISPR-Cas13 (clustered regularly interspaced short palindromic repeats-associated 13) system for detecting FAdV-4 as well as kit and method thereof

    CN115807124A